Company / Interest Expense per Share
NovoCure Ltd Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.20
FY2025
5-year range
$0.05 / $0.20
FY2021-FY2025
Trend
+88.0%
vs FY2024
Sector context
#32 of 40
Health Care
What the data says
NovoCure Ltd's interest expense per share of $0.20 is lower than 80% of companies in the Health Care sector (FY2025). Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.05 in FY2023 to $0.20 in FY2025.
Based on SEC 10-K filings.
0.20 in FY2025 with a 5-year CAGR of +2.5%.
Increased from $0.05 to $0.20 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +37.9%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 40This company $0.20 Sector average $1.56
▼
-86.9% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 88.0% year-over-year.
- Ranks #32 out of 40 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.20 | +88.0% |
| FY2024 | $0.11 | +133.2% |
| FY2023 | $0.05 | -40.1% |
| FY2022 | $0.08 | -9.7% |
| FY2021 | $0.09 | -52.4% |
| FY2020 | $0.18 | +15.5% |
| FY2019 | $0.16 | -16.9% |
| FY2018 | $0.19 | +40.7% |
| FY2017 | $0.13 | +53.8% |
| FY2016 | $0.09 | -63.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026